Genetic basis for mutacin N and of its relationship to mutacin I

Indian Journal of Medical Research, Supplement

Volumn 119, Issue MAY, 2004, Pages 247-251

  Hale, J D F ^a   Balakrishnan, M ^a   Tagg, John R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Bacteriocin; Like inhibitory substance; Mutacin; Streptococcus mutans

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; BACTERIOCIN; MUTACIN I; MUTACIN N; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA DETERMINATION; DOT HYBRIDIZATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; HUMAN; MOLECULAR CLONING; RESTRICTION FRAGMENT; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SOBRINUS; STRUCTURAL GENE;

BACTERIOCINS; BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; STREPTOCOCCUS;

EID: 3442882527     PISSN: 03679012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hamada D, Ooshima T. Inhibitory spectrum of a bacteriocin like substance (mutacin) produced by some strains of Streptococcus mutans. J Dent Res 1975; 54: 140-5.
2. Balakrishnan M, Simmonds RS, Kilian M, Tagg JR. Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenetic lineages. J Med Microbiol 2002; 51: 941-8.
3. Balakrishnan M, Simmonds RS, Carne A, Tagg JR. Streptococcus mutans strain N produces a novel low molecular mass non- lantibiotic bacteriocin. FEMS Microbiol Lett 2000; 183: 165-9.
4. Qi F, Chen P, Caufield PW. The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV. Appl Environ Microbiol 2001; 67: 15-21.
5. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Laboratory Press; 1989.
6. Sheng Y, Mancino V, Birren B. Transformation of Escherichia coli with large DNA molecules by electroporation. Nucleic Acids Res 1995; 23: 1990-6.
7. Triglia T, Peterson MG, Kemp DJ. A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences. Nucleic Acids Res 1988; 16: 8186.
8. Upton M, Tagg JR, Wescombe P, Jenkinson HF. Intra-and interspecies-signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J Bacteriol 2001; 183: 3931-8.
9. Tagg JR, Bannister, LV. "Fingerprinting" β-haemolytic streptococci by their production of and sensitivity to bacterocine like inhibitors. J Med Microbiol 1979; 12: 397-411
10. de Saizieu A, Gardes C, Flint N, Wagner C, Kamber M, Mitchell TJ, et al. Microarray-based identification of a novel Streptococcus pneumoniae regulon controlled by an autoinduced peptide. J Bacteriol 2000; 182: 4696-703.
11. Qi F, Chen P, Caufield PW. Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes. Appl Environ Microbiol 2000; 66: 3221-9.
12. Chikindas M L, Novak J, Driessen JM, Konings WN, Schilling KM, Canfield PW, et al. Mutacin II, a bactericidal lantibiotic from Streptococcus mutans. Antimicrob Agents Chemother 1995; 39: 2656-60.
13. Qi F, Chen P, Caufield PW. Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes. Appl Environ Microbiol 1999; 65: 3880-7.
14. Mota-Meira M, Lacroix C, LaPointe G, Lavoie MC. Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans. FEBS Lett 1997; 410: 275-9.
15. Marciset O, Jeronimus-Stratingh MC, Mollet B, Poolman B. Thermophilin 13, a nontypical antilisterial poration complex bacteriocin, that functions without a receptor. J Biol Chem 1977; 272: 14277-84.
16. Moll G, Ubbink-Kok T, Hildeng-Hauge H, Nissen-Meyer J, Nes IF, Konings WN, et al. Lactococcin G is a potassium ion-conducting, two-component bacteriocin. J Bacteriol 1996; 178: 600-5.
17. McAuliffe O, Hill C, Ross RP. Each peptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity. Microbiology 2000; 146: 2147-54.
18. Navaratna MA, Sahl HG, Tagg JR. Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol 1998; 64: 4803-8.
19. Li YH, Lau PC, Lee JH, Ellen RP, Cvitkovitch DG. Natural genetic transformation of Streptococcus mutans growing in biofilms. J Bacteriol 2001; 183: 897-908.